|
|
||||||||
See also pages 1130, 1183, 1187, and 1241, From the Department of Neurology (Drs. Danisi, Morrison, Velickovic, Brin, and Silverman, D. Doheny and C. Smith), Mount Sinai School of Medicine, and Department of Neurology (D. de Leon and Dr. Bressman), Beth Israel Medical Center, New York, NY; Department of Neurology (J. Leung and X. Breakefield), Massachusetts General Hospital and Harvard Medical School, Charlestown, MA; Department of Molecular Genetics (Dr. Ozelius), Albert Einstein College of Medicine, Bronx, NY; and Department of Neurology (Dr. Klein), Medical University of Lübeck, Germany.
Address correspondence and reprint requests to Dana O. Doheny, MS, Department of Neurology, Mount Sinai School of Medicine, Annenberg 14-51A, Box 1052, New York, NY; e-mail: Dana.Doheny{at}mssm.edu
Myoclonus-dystonia has recently been associated with mutations in the epsilon-sarcoglycan gene (SCGE) on 7q21. Previously, the authors reported a patient with myoclonus-dystonia and an 18-bp deletion in the DYT1 gene on 9q34. The authors have now re-evaluated the patient harboring this deletion for mutations in the SGCE gene and identified a missense change. In the current study, the authors describe the clinical details of this family carrying mutations in two different dystonia genes. Further analysis of these mutations separately and together in cell culture and in animal models should clarify their functional consequences.
This article has been cited by other articles:
![]() |
F. Yokoi, M. T. Dang, S. Mitsui, J. Li, and Y. Li Motor Deficits and Hyperactivity in Cerebral Cortex-specific Dyt1 Conditional Knockout Mice J. Biochem., January 1, 2008; 143(1): 39 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yokoi, M. T. Dang, J. Li, and Y. Li Myoclonus, Motor Deficits, Alterations in Emotional Responses and Monoamine Metabolism in {varepsilon}-Sarcoglycan Deficient Mice J. Biochem., July 1, 2006; 140(1): 141 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Tezenas du Montcel, F Clot, M Vidailhet, E Roze, P Damier, C P Jedynak, A Camuzat, A Lagueny, L Vercueil, D Doummar, et al. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes J. Med. Genet., May 1, 2006; 43(5): 394 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kock, T. V. Naismith, H. E. Boston, L. J. Ozelius, D. P. Corey, X. O. Breakefield, and P. I. Hanson Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier Hum. Mol. Genet., April 15, 2006; 15(8): 1355 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Han, A. E. Lang, L. Racacho, D. E. Bulman, and D. A. Grimes Mutations in the {epsilon}-sarcoglycan gene found to be uncommon in seven myoclonus-dystonia families Neurology, July 22, 2003; 61(2): 244 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M.J. Foncke, C. Klein, J. H.T.M. Koelman, P. L. Kramer, K. Schilling, B. Muller, J. Garrels, P. de Carvalho Aguiar, L. Liu, A. de Froe, et al. Hereditary myoclonus-dystonia associated with epilepsy Neurology, June 24, 2003; 60(12): 1988 - 1990. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Furukawa and A. H. Rajput Inherited myoclonus-dystonia: How many causative genes and clinical phenotypes? Neurology, October 22, 2002; 59(8): 1130 - 1131. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |